Retinal Vein Occlusion: Risk Factors and Injections Explained

When you wake up one morning and notice your vision is blurry or dark in one eye - no pain, no warning - it can be terrifying. For many, this is the first sign of retinal vein occlusion (RVO), a serious eye condition that blocks the tiny veins carrying blood away from the retina. It doesn’t happen overnight, but it hits fast. And if left untreated, it can lead to permanent vision loss. The good news? We now have effective treatments, especially injections that can save sight. But knowing your risks and what to expect from treatment makes all the difference.

What Exactly Is Retinal Vein Occlusion?

The retina is the light-sensitive layer at the back of your eye. It turns images into signals your brain understands. When a vein in the retina gets blocked, fluid leaks out, swelling the macula - the center part of the retina responsible for sharp, detailed vision. This swelling, called macular edema, is what blurs your vision.

There are two main types of RVO:

Central Retinal Vein Occlusion (CRVO): The main vein is blocked. This usually causes more severe vision loss.
Branch Retinal Vein Occlusion (BRVO): A smaller branch vein is blocked. Vision loss is often partial, affecting just one part of your visual field.

Both happen because of a clot or compression - often where a stiff artery crosses over a vein and squeezes it shut. Think of it like a kinked garden hose. Blood backs up, fluid leaks, and the retina swells. This isn’t just a one-time event. Without treatment, the swelling can keep coming back.

Who’s Most at Risk?

RVO isn’t random. It’s tied to long-term health habits and conditions. Most cases happen after age 55, and over half occur in people over 65. But it’s not just about age.

High blood pressure is the biggest risk factor. Up to 73% of CRVO patients over 50 have uncontrolled hypertension. Even if you think your blood pressure is "okay," consistently high numbers damage blood vessels over time.
Diabetes affects about 10% of RVO patients over 50. High blood sugar weakens tiny blood vessels, making them more likely to leak or clot.
High cholesterol (total cholesterol above 6.5 mmol/L) is found in 35% of all RVO cases. Fatty deposits build up in artery walls, increasing pressure and narrowing blood flow.
Glaucoma and high eye pressure raise the risk, especially if the blockage happens near the optic nerve.
Smoking is involved in 25-30% of cases. It thickens blood, damages vessel walls, and speeds up hardening of the arteries.
Obesity and lack of movement contribute. Sedentary lifestyles worsen circulation and increase inflammation.

For younger people under 45, the story changes. About 5-10% of RVO cases happen in this group. Here, the biggest red flags are:

Oral contraceptives - especially in women with other risk factors like high blood pressure.
Blood disorders like polycythemia vera, multiple myeloma, or inherited clotting problems (like factor V Leiden).

If you’re under 50 and get RVO, your doctor should run tests for these hidden causes. It’s not just an eye problem - it’s a warning sign.

How Do Injections Help?

Injections into the eye - yes, really - are now the standard treatment. They don’t fix the blocked vein. Instead, they stop the damage the blockage causes: swelling in the macula.

Two types of injections are used:

Anti-VEGF drugs: These block a protein called VEGF that causes fluid leakage. Common ones include ranibizumab (Lucentis), aflibercept (Eylea), and bevacizumab (Avastin - used off-label).
Corticosteroid implants: Like Ozurdex, a tiny implant that slowly releases steroid into the eye to reduce inflammation.

Clinical trials show these work. In the BRAVO trial, patients using ranibizumab gained an average of 16.6 letters on an eye chart after a year. That’s like going from reading 20/200 to 20/60 - enough to recognize faces and read large print.

Aflibercept did even better in some cases. The COPERNICUS trial showed a 18.3-letter gain on average. And Ozurdex helped 27.7% of CRVO patients gain 15 or more letters - a big jump for those who didn’t respond to anti-VEGF.

A patient receiving a painless eye injection to treat retinal swelling.

What to Expect During Treatment

Getting an injection sounds scary, but it’s quick and routine. Here’s what happens:

You’ll get numbing drops in your eye.
Your eye is cleaned with antiseptic.
A tiny speculum holds your eyelid open.
The doctor injects the medicine through the white part of your eye - not the front.
The whole thing takes 5-7 minutes.

Most people feel pressure but not pain. You might see floaters or have a small red spot on the white of your eye afterward. That’s normal. Serious infections like endophthalmitis happen in less than 0.1% of cases.

Treatment isn’t one-and-done. Most patients need injections every 4-6 weeks at first. Once swelling improves, your doctor may switch to a "treat-and-extend" plan - where you get injections less often, based on how your eye responds. Real-world data shows patients need 8-12 injections per year on average to maintain vision.

Cost and Real-Life Challenges

This is where things get tough. Anti-VEGF drugs are expensive. In the U.S., Lucentis and Eylea cost around $2,000 per dose. Avastin, which is the same drug but repackaged from cancer treatment, costs about $50. That’s why many safety-net clinics use Avastin - it works just as well.

But cost isn’t the only burden. Many patients report:

Financial strain - $150-$2,000 per injection adds up fast.
Treatment fatigue - going to the clinic every month for over a year is exhausting.
Anxiety - the fear of needles, even when you know it’s safe.

One patient on a support forum said: "I missed three appointments because I was too scared to go. Then my vision got worse again." Another said: "The Ozurdex implant changed my life - one shot gave me 10 lines of vision back. Worth every penny." Three treatment options for retinal vein occlusion compared with healthy vs. damaged retina.

Three treatment options for retinal vein occlusion compared with healthy vs. damaged retina.

What’s New in Treatment?

The field is moving fast. New approaches aim to reduce how often you need injections:

Port Delivery System (Susvimo): A tiny refillable implant placed in the eye that releases ranibizumab for months. Approved for AMD, trials for RVO are underway.
Gene therapy: RGX-314 is being tested to make your eye produce its own anti-VEGF protein - potentially eliminating injections altogether.
Combination therapy: Some doctors now mix anti-VEGF with steroids for patients who don’t respond to one alone.

Studies show that treat-and-extend protocols work just as well as monthly shots - but with 30% fewer injections. That’s a game-changer for quality of life.

What You Can Do

If you’re at risk - or already have RVO - here’s what matters most:

Control your blood pressure. Even small drops in numbers help.
Manage diabetes and cholesterol. Get regular labs.
Quit smoking. No exceptions.
Move daily. A 20-minute walk improves circulation.
See your eye doctor every 3-6 months if you’ve had RVO. Monitoring with OCT scans catches swelling before it hurts vision.
Ask about treatment options. Don’t assume one drug is right for everyone.

Vision loss from RVO isn’t inevitable. With the right care, most people stabilize or improve. But it takes time, consistency, and knowing your options.

Can retinal vein occlusion be cured?

No, RVO itself can’t be cured - the blocked vein doesn’t reopen. But the damage it causes - like macular edema - can be controlled. Injections stop fluid buildup, preserve vision, and often improve it. Many patients maintain good vision for years with ongoing treatment.

Are eye injections painful?

Most patients feel pressure or a brief pinch, but not sharp pain. Numbing drops are used, and the procedure takes less than 10 minutes. Some report mild irritation or a scratchy feeling afterward, but it fades within hours.

How long until I see improvement after an injection?

Some patients notice better vision within days. For most, it takes 2-6 weeks. OCT scans track swelling reduction, which is the real sign of progress. Don’t expect instant results - consistent treatment over months is what matters.

Can I get RVO in both eyes?

Yes, but it’s rare. Most cases affect only one eye. If you’ve had RVO in one eye, your risk of it happening in the other increases slightly - especially if underlying conditions like high blood pressure or diabetes aren’t controlled. Regular eye exams are critical.

Is there a difference between Avastin, Lucentis, and Eylea?

All three block VEGF and work similarly. Clinical trials show Eylea and Lucentis have slightly better average results in some cases. But Avastin, which costs 40 times less, is just as effective for most people. The choice often comes down to cost, insurance coverage, and doctor preference.

Final Thoughts

Retinal vein occlusion isn’t just an eye issue - it’s a signal from your body. It’s telling you something’s wrong with your blood vessels. The injections help you keep your sight. But the real win comes from managing the root causes: your blood pressure, your sugar, your cholesterol, your lifestyle. Treat the eye, yes - but don’t ignore the rest of your health. That’s where lasting vision protection begins.